Wooree Bio Co.,Ltd (KOSDAQ: 082850)

Wooree Bio Co.,Ltd Statistics

Total Valuation

Wooree Bio Co.,Ltd has a market cap or net worth of KRW 192.13 billion. The enterprise value is 195.86 billion.

Market Cap	192.13B
Enterprise Value	195.86B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Wooree Bio Co.,Ltd has 47.21 million shares outstanding. The number of shares has decreased by -0.02% in one year.

Shares Outstanding	47.21M
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	-1.07%
Owned by Insiders (%)	3.68%
Owned by Institutions (%)	7.27%
Float	30.59M

Valuation Ratios

The trailing PE ratio is 12.19.

PE Ratio	12.19
Forward PE	n/a
PS Ratio	0.15
PB Ratio	0.91
P/FCF Ratio	7.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.27, with an EV/FCF ratio of 7.40.

EV / Earnings	12.34
EV / Sales	0.15
EV / EBITDA	3.27
EV / EBIT	6.48
EV / FCF	7.40

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.42.

Current Ratio	1.52
Quick Ratio	1.13
Debt / Equity	0.42
Debt / EBITDA	1.86
Debt / FCF	4.23
Interest Coverage	5.40

Financial Efficiency

Return on equity (ROE) is 9.04% and return on invested capital (ROIC) is 5.25%.

Return on Equity (ROE)	9.04%
Return on Assets (ROA)	3.03%
Return on Capital (ROIC)	5.25%
Revenue Per Employee	10.52B
Profits Per Employee	127.95M
Employee Count	124
Asset Turnover	2.08
Inventory Turnover	10.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +103.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+103.48%
50-Day Moving Average	4,776.90
200-Day Moving Average	3,411.83
Relative Strength Index (RSI)	37.10
Average Volume (20 Days)	10,704,091

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Wooree Bio Co.,Ltd had revenue of KRW 1.30 trillion and earned 15.87 billion in profits. Earnings per share was 333.85.

Revenue	1.30T
Gross Profit	127.13B
Operating Income	30.40B
Pretax Income	27.42B
Net Income	15.87B
EBITDA	60.03B
EBIT	30.40B
Earnings Per Share (EPS)	333.85

Balance Sheet

The company has 166.02 billion in cash and 111.89 billion in debt, giving a net cash position of 54.13 billion or 1,146.56 per share.

Cash & Cash Equivalents	166.02B
Total Debt	111.89B
Net Cash	54.13B
Net Cash Per Share	1,146.56
Equity (Book Value)	268.17B
Book Value Per Share	4,457.07
Working Capital	180.57B

Cash Flow

In the last 12 months, operating cash flow was 44.17 billion and capital expenditures -17.69 billion, giving a free cash flow of 26.48 billion.

Operating Cash Flow	44.17B
Capital Expenditures	-17.69B
Free Cash Flow	26.48B
FCF Per Share	560.98

Margins

Gross margin is 9.75%, with operating and profit margins of 2.33% and 1.22%.

Gross Margin	9.75%
Operating Margin	2.33%
Pretax Margin	2.10%
Profit Margin	1.22%
EBITDA Margin	4.60%
EBIT Margin	2.33%
FCF Margin	2.03%

Dividends & Yields

Wooree Bio Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.02%
Shareholder Yield	0.02%
Earnings Yield	8.20%
FCF Yield	13.78%

Stock Splits

The last stock split was on May 4, 2009. It was a forward split with a ratio of 2.

Last Split Date	May 4, 2009
Split Type	Forward
Split Ratio	2

Scores

Wooree Bio Co.,Ltd has an Altman Z-Score of 2.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.77
Piotroski F-Score	n/a